Recent Posts by E3X

E3X Bio recieves Grant from Thiel Foundation’s Breakout Labs

E3x Bio is the first company with exclusive focus on inhibitors and activators of E3 Ubiquitin (Ub) ligases for drug discovery and development. This class of medically relevant enzymes is considered an important target for diseases ranging from cancer to neurodegeneration, but has been inaccessible to high-throughput drug screening because the current assays are cumbersome,...

Read more

Recent Comments by E3X

    No comments by E3X yet.